Amy Rivas
Nurse Practitioner · San Antonio, TXNPI 1699244830
Payments from drug & device makers
Across 575 payments — averaging $29.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$4K
- Medtronic$3K
- Lilly USA, LLC$1K
- Corcept Therapeutics$842
- Sequel Med Tech, LLC$746
- Abbott$600
- plus $7K from 45 others
What the payments were for
- Travel & lodging$1,1867%
- Food & beverage$15,70093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,193
- iLet Bionic Pancreas$569
- TWIIST$549
- Korlym$487
- FREESTYLE LIBRE 3$401
- TEPEZZA$273
- Wegovy$268
- ZEPBOUND$250
- Ozempic$245
- CeQur Simplicity$239
- RYBELSUS$223
- Saxenda$213
- Signia$160
- REZDIFFRA$150
- INPEN SMART INSULIN DELIVERY SYSTEM$150
- ENROUTE .014 Guidewire$143
- ENHANCE Transcarotid Peripheral Access Kit$143
- ENROUTE Transcarotid Neuroprotection System$143
- ENROUTE Transcarotid Stent$143
- Omnipod$128
How this compares
$16,886 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 115 | $130,435 |
| OzempicSemaglutide | 51 | $62,125 |
| TrulicityDulaglutide | 15 | $15,153 |
| Omeprazole | 14 | $253 |
| Levothyroxine Sodium | 30 | $204 |
| Metformin Hcl | 15 | $131 |
| Metformin Hcl ErMetformin Hcl | 25 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $1,493 | $145,588130 claims |
| Novo NordiskOzempic | $3,796 | $62,12551 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in San Antonio
- Corrie BerkSan Antonio$155K
- Sonja BruneSan Antonio$51K
- Laura GalvanSan Antonio$32K
- Eduardo GonzalezSan Antonio$32K
- Roberta RomeroSan Antonio$26K
- Christopher GarciaSan Antonio$21K
- Jennifer ZavalaSan Antonio$17K
- Erika SimpsonSan Antonio$16K
- Alexis WahlenSan Antonio$16K
- Cecilia DavisAustin$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.